<DOC>
	<DOCNO>NCT02057666</DOCNO>
	<brief_summary>To confirm effect tasquinimod delay disease progression death compare placebo chemo-naïve patient metastatic castrate-resistant prostate cancer ( mCRPC ) .</brief_summary>
	<brief_title>Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Asian male age least 20 year time signing informed consent form Histologically confirm diagnosis adenocarcinoma prostate Evidence metastatic disease ( bone and/or visceral ) , exclude node lesion , radiographic examination , whether bone scan ( bone lesion ) image modality ( compute tomography [ CT ] scan/magnetic resonance image [ MRI ] ) Chemical surgical castration verify level serum testosterone ≤50 ng/dL ( 1.75 nmol/L ) , Evidence progressive disease castration level testosterone achieve Cytotoxic chemotherapy treatment prostate cancer within 2 year prior start study treatment Previous anticancer therapy use radiation , biologics vaccine include sipuleucelT ( Provenge® ) within 4 week prior start study treatment abiraterone , TAK700 MDV3100 within 2 week prior start study treatment . Before inclusion , abiraterone , TAK700 MDV3100 related adverse effect must resolve NCICTCAE v4.03 Grade ≤1 . If radiation therapy apply Baseline scan , new Baseline scan need do least 4 week radiation therapy Therapy antiandrogens within 4 week ( within 6 week bicalutamide e.g . Casodex® ) prior start study treatment Concurrent use anticancer agent treatment , exception ongoing treatment luteinising hormonereleasing hormone agonist antagonist , denosumab ( Prolia® ) bisphosphonate ( e.g . zoledronic acid ) , allow . Ongoing treatment keep stable schedule ; however , medically require , change dose , compound , allow Prostate cancer pain require ongoing treatment narcotic analgesic warrant initiation radio chemotherapy ProstateSpecific Antigen ( PSA ) &gt; 100 ng/mL</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>